Comparison between intravenous sodium valproate and subcutaneous sumatriptan for treatment of acute migraine attacks; double- blind randomized clinical trial
IJMS-Iranian Journal of Medical Sciences. 2014; 39 (2 Supp.): 171-177
in English
| IMEMR
| ID: emr-177209
ABSTRACT
Background:
Sodium valproate [SV] has been approved for migraine prophylaxis and its intravenous form is used to treat acute migraine attacks. We compared the efficacy and safety of intravenous SV and subcutaneous Sumatriptan in managing acute migraine attacks
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Controlled clinical trial
Language:
English
Journal:
Iran. J. Med. Sci.
Year:
2014
Similar
MEDLINE
...
LILACS
LIS